Celgene Can't 'Guess' How Rival Mylan Operates, Judge Says
By Christopher Cole ( September 2, 2021, 7:38 PM EDT) -- A Federal Circuit judge pressed pharma giant Celgene Corp. on Thursday to explain why it's not just making a "guess" as to the roles played by various Mylan entities in allegedly trampling Celgene's patents on the blockbuster cancer drug Pomalyst....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.